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 Electrical stimulation modulates cellular process in a form of 
ionic current through regulating cell membrane potential. Electrical 
stimulation has effects of up-regulation of cell proliferation rate 
and cell viability. As a good osteoinductive tool, electrical 
stimulation has effects of differentiation to bone cell, acceleration of 
ossification and calcium induction that improve bone regeneration. 
Although implantable electrical stimulation devices for bone 
regeneration were commercialized, there was limitation for applying 
to bone graft transplantation due to the shape of the device and 
stimulation delivery.  
 In the present dissertation, implantable bone regeneration 
device using electrical stimulation is demonstrated. The device can 
deliver a concentrated electrical stimulation to three-dimensional 
bone graft. The evaluation of bone regeneration targeting animal 
bone defect model using the designed device is demonstrated.  
 As a preliminary step for developing bone regeneration 
device, a bioreactor device which allows intracorporeal cell culture 
using electrical stimulation was designed. Using this device, human 
mesenchymal stromal cell was cultured intracorporeally with 
electrical stimulation. The cell proliferation of the electrical 
stimulated stem cell was increased by 23% compared to the 
unstimulated stem cell. Also in the electrically stimulated group, 
stem cell had more stable adhesion to the collagen sponge and 
better extracellular matrix formation compare to the control group. 
 
 ii
 Through improvement of the bioreactor device, bone 
regeneration experiment targeting a rabbit mandible was executed 
by transplantation of stem cell graft and electrical stimulation 
device into the defect site. Polyimide electrode was designed to be 
suited the defect of animal and electrical current generator was 
packaged with silicone. The electrical stimulated group showed a 
higher bone volume by 260% compared with unstimulated group. 
Also electrical stimulated group showed better new bone formation 
results in various bone parameters. 
 Then LCP-based bone regeneration device was designed 
with a built-in electrical current generator and wireless power 
receiver device. LCP has good hermeticity and good osseo-
integration property. This device performs a graft containment 
system and electrical stimulation device simultaneously.  
 From these results, bone regeneration treatment using 
implantable bone regeneration device which can apply electrical 
stimulation to defect site directly can be an effective and new 
methods for bone defect recovery. Furthermore, it can be expected 
that development of implantable bone regeneration device using 
LCP and development of combined treatment of intracorporeal stem 
cell culture and electrical stimulation. 
 
Keywords: Electrical stimulation, implantable device, bone 
regeneration, stem cell, LCP 
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Chapter 1 Introduction 
 
 
1.1 Regulation of cellular process through electrical 
stimulation 
 
Neural prosthetic devices including artificial retina and cochlear 
implant, neuro modulation devices such as deep brain stimulation 
device, cell culture systems and tissue regeneration devices using 
electrical stimulation regulate action of nerve system and modulate 
cellular process through electrical stimulation [1-5]. Electrical 
stimulation which can be applied in forms of constant 
voltage/current or pulsed voltage/current, affects living body 
through electrode that mediates hardware such as voltage/current 
source and liveware such as neuron and tissue [6]. The hardware, 
the liveware and the electrode comprise electrochemical cell in 
figure 1.1 [7]. Electrochemical cell is a system that more than a 
pair of electrodes which are connected to power supply inserted 
into electrolyte. The each of electrodes acts cathode and anode. If 
current or voltage is generated by power supply of electrochemical 
cell, oxidation occurs at the anode and reduction occurs at the 
cathode. At this moment, oxidation current generated by oxidation 
at the anode has a same level with reduction current generated by 
reduction at the cathode. And a current which has same level of the 
oxidation current and reduction current flows through power supply 
and electrolyte between the anode and the cathode. The current 
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from electron and negative ion forms a closed loop. And the current 
flows a circuit of electrochemical cell when tracing flow of electron 
and negative ion in electrochemical cell. A term of stimulating 
biological tissue using electric stimulation device means that to 
construct an electrochemical cell of electrode, tissue and 
stimulation device, and to make the current flow each component 
forming a closed loop. The current flows forming a closed loop 
modulate cellular process. In this chapter, when electrical 
stimulation is generated from electrical stimulation device, how 
does a charge transfer to liveware and how does the liveware sense 
this charge flow and modulate cellular process will be demonstrated.  
 
 




1.1.1 Charge transfer at interface of electrode 
/electrolyte 
 
When electricity is generated from power source of electrical 
device, current flows in a closed loop circuit consisted of electrode, 
tissue and power source. Current is a flow of charge. When a 
charge moves to electrode, energy of electron rises. The energy of 
electron rise when a potential of electrode increases to negative 
direction. Figure 1.2 demonstrates a process that movement and 
accumulation of electrons according to change of the energy of 
electron. A movement tendency of electron from electrode to 
electrolyte can be expected by comparing electron energy of 
electrode and compound in electrolyte. If Fermi level of electron in 
electrode is lower than highest occupied molecular orbital (HOMO) 
of compound in electrolyte, movement of electron from electrode to 
electrolyte – oxidation is possible. By contrast, Fermi level of 
electron in electrode is higher than lowest unoccupied molecular 
orbital (LUMO) of compound in electrolyte, movement of electron 






Figure 1.2 A conceptual diagram of movement and accumulation of 
electron according to increase of electron energy in electrode [7]. 
 
When electron transfers to electrolyte, electron transfers by 
capacitive process and faradaic process. Figure 1.3 demonstrates 
how the two processes occur in electrode and deliver electron. If 
negative potential or negative current applied in electrode, electrons 
move to electrode and electron energy increases. The electrons 
accumulate in the electrode and the electron energy increase 
continuously until the electron energy reaches to level of LUMO 
because electrons can transfer from electrode to electrolyte when 
the electron energy is higher than LUMO of electrolyte 
thermodynamically. At that moment, to maintain charge neutrality, 
cations from electrolyte move to electrode and form an electric 
double layer of 10~100 Å thickness at the surrounding of 
electrode. The electrons accumulate until the electron energy reach 
to LUMO level of compound in electrolyte. Therefore the electric 
double layer acts as a capacitor. The current which flows with 
charging electric double layer is called to be a capacitive current or 
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a double layer charging current. When a capacitive current flows, a 
same amount of displacement current arises by ions in electrolyte.  
 
 
Figure 1.3 Two charge transfer process at electrode/electrolyte 
interface. [8] 
 
Faradaic current is a current from electron transfer by chemical 
process when the electron energy in electrode exceeds LUMO level 
of compound in electrolyte. Amount of faradaic current is affected 
by speed of mass transfer and chemical reaction because the 
faradaic current arises from reduction/oxidation reaction between a 
surface of metal electrode and electrolyte.  
From a fact that the charge transfer is conducted by the two 
processes at electrode and electrolyte interface, we can know a 
process that the current generated from a power supply device is 
transduced a summation of faradaic current and double layer 
charging current at electrode/electrolyte interface. The 
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electrode/electrolyte interface can be modeled in equivalent circuit 
model as figure 1.4, because the charge transfer is generated at the 
electrode/electrolyte interface. In this model, a capacitor 
demonstrates a charge of electric double layer, faradaic impedance 
means charge transfer and mass transfer which make chemical 
reaction. Otherwise, electrochemical reaction occurs in several 
hundred micro meters around electrode, so electron transfer from 
faradaic process does not be transfer to a bulk area in where a 
tissue should be stimulated is located.  
At electrode/electrolyte interface, there is current from electron 
transfer and displacement current due to the two charge transfer 
processes. In bulk region a tissue and cells are affected by an ionic 
current which is same amount of the current from the two 
processes.   
 
 





1.1.2 Electrical equivalent circuit modeling of cellular 
membrane  
 
It is necessary that electrical equivalent circuit modeling of cell to 
explore a modulation of electrical characteristic of cell due to ionic 
current applied from external electrical device. There is difference 
of amount of charge between interior of cell and extracellular space 
basically, and cells maintain a homeostasis in order that intracellular 
potential has a negative potential about -80 mV to -40 mV 
compared to extracellular potential [9]. Figure 1.5 demonstrates 
that which ions distribute in extracellular and intracellular spaces 
and which components are embedded in plasma membrane. Also it 
demonstrates electrical potential across plasma membrane that is 





Figure 1.5 Structure of cellular membrane and ion distribution across 
plasma membrane [10] 
 
In extracellular space, chloride and sodium ions are many compare 
to intracellular space. In intracellular space, potassium ions and 
anions such as amino acid are many compare to extracellular space. 
Separation of ion concentration across plasma membrane is possible 
through a special structure called a lipid bilayer. Figure 1.6 shows a 





Figure 1.6 Structure of lipid bilayer [11] 
 
Phospholipid consists of hydrophilic head and hydrophobic leg. A 
pair of phospholipid makes face to face each other with its 
hydrophobic leg and this pair of phospholipid comprises plasma 
membrane. Ions in extracellular and intracellular space cannot move 
across plasma membrane because two-dimensional structure of 
hydrophilic head of phospholipid comprise interface of intracellular 
and extracellular space and hydrophobic layer of phospholipid leg is 
located in a center of plasma membrane. Ion distribution in 
extra/intracellular space is separated and potential difference is 
generated according to existence of lipid bilayer. As mentioned 
above the potential of intracellular space is lower than the potential 
of extracellular space, but bulk region of extra/intra cellular space 
maintains charge neutrality. Most potential difference is applied to 
the plasma membrane. Anions and cations are arranged with the 
plasma membrane. The potential difference with extra/intra cellular 
space that is the potential which arise from accumulation of anions 
and cations across the plasma membrane is called a transmembrane 
potential [12]. Ions cannot move through plasma membrane and 
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cation and anion accumulate according to transmembrane potential, 
plasma membrane has same characteristic of capacitor. Plasma 
membrane is modeled by capacitor and capacitance per unit area of 
plasma membrane is reported as 1 μF/cm2 [13]. 
Plasma membrane has another special cellular structure ion channel 
which allows ion movements across plasma membrane. Ion channel 
consists of several units of proteins. Each ion channel is named 
after ions that ion channel pass through. To maintain homeostasis, 
separation of ion concentration across plasma membrane regulates 
transmembrane potential with ion channels. The existence of ion 
channel which allows special ion to pass through plasma membrane 
and separated ion concentration make electrical potential difference 
at each ion channel. And the potential difference from each ion 
channel affects transmembrane potential. Before exploring effects 
of each ion in intra/extra cellular space on to the transmembrane 
potential, let’s derive a general equation of specific ion channel 
effect on transmembrane potential. After that, the effect of every 
ion on the transmembrane potential can be derived by expanding the 
equation of specific ion to case of every ion. For example, let’s 
consider an ion channel that only pass potassium ion. There is 
difference of ion concentration of potassium at across of the plasma 
membrane. Potassium ion diffuses from intra cellular space in which 
has higher potassium ion concentration to extra cellular space in 
which has lower potassium ion concentration. This diffusion is a 
current because ion diffusion, the current is called a diffusion 
current of potassium. The diffusion current can be explained 
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following equation by Fick’s first law [9]. 
 
   (1.1) 
 
Furthermore, due to potential difference of transmembrane potential, 
electric field is formed at across plasma membrane. Ions move by 
this electric field. The current formed by the electric field from 
transmembrane potential is called a drift current. Drift current can 
be explained following equation by Ohm’s law [9].  
 
  (1.2)  
 
It can be considered a dynamic equilibrium state in that a 
summation of drift current and diffusion current is zero at potassium 
channel. In this condition, a summation of equation 1.1 and 1.2 is 




Then using Einstein equation (equation 1.4), equation 1.5 can be 








Then solving integral from extra cellular region to intra cellular 






Equation 1.7 is called to be a Nernst equation and corresponding ion 
makes a dynamic equilibrium state when transmembrane potential is 
Nernst potential of that ion [12]. That is to say, in case that ion 
separation due to selective permeable membrane is occurred and 
there is only one ion channel for corresponding ion, that ion cannot 
make dynamic equilibrium state and undergo diffusion and drift 
through ion channel until the Nernst potential. The separation of ion 
concentration and existence of ion channel drive the potential 
across ion channel. Therefore ion channel can be modeled as a 
battery that has electromotive force as much as Nernst potential 
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[12]. Also the ion channel is passage of ion, so this is modeled as a 
conductance [9]. 
Furthermore Nernst equation of specific ion can be apply to every 
ion that has separated ion concentration and ion channel, each ion 
can be modeled as a series circuit of battery and conductance [9]. 
Of course every ion has different ion concentration each other, so 
Nernst potential of each ion - potential that ion drives is different 
each other. Table 1.1 shows some Nernst potentials according to 
ion distribution in neuronal cell [12].  
 
Table 1.1 Nernst potentials and ion concentrations of some ions in 
neuron.  




Potassium 400 20 -74 
Sodium 50 440 55 
Chloride 52 560 -60 
 
Cells maintain transmembrane potential at resting state. General 
transmembrane potential is differ to Nernst potentials of each ion. 
This means that each ion undergo diffusion and drift continuously 
and maintain dynamic equilibrium state at given transmembrane 
potential. Therefore according to space charge neutrality, cathodal 
current and anodal current flow across plasma membrane should be 






On the other hand, in resting state, for the transmembrane potential 





Then equation 1.9 is substituted into equation 1.8, and introducing a 
concept of permeability shown in equation 1.10, equation 1.11 is 







Permeability is proportional to mobility of ion. It expresses how 
each ion diffuses or drifts easily. This is related to conductance of 
each ion channel directly. A large permeability or a large 
conductance means that corresponding ion channel can pass ion 
easily. If there are many ion channels or many ion channels are 
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open, permeability and conductance are large. Now let’s change 
equation 1.11 to equation 1.12 to make integration. Then solving 
integral from intra cellular region to intra cellular region (equation 








Equation 1.15 can be derived from arranging equation 1.14, from 
this equation, equations of cathodal current and anodal current of 










Then substitution of equation 1.16 and 1.17 to equation 1.8 and 




This equation can be change to equation 1.19 and solving for V, 
finally equation 1.20 is derived. This equation is called a Goldman’s 






From Goldman’s equation, it is considerable that permeability and 
conductance of each ion, a condition of ion channel in plasma 
membrane, and ion concentration affect to formation of 
transmembrane potential of cell directly. When conductance of 
specific ion channel is large, the transmembrane potential 
 
 17
converges to Nernst potential of corresponding ion. The 
transmembrane potential of cell is determined by separation of ion 
concentration for maintaining cell homeostasis and distribution or 
gating condition of ion channel. Now, using components that 
determine transmembrane potential of cell, equivalent circuit model 
of plasma membrane is shown in figure 1.7  
 
 
Figure 1.7 Equivalent circuit of plasma membrane [9] 
 
The capacitor demonstrates lipid bilayer of plasma membrane, the 
series circuit of the battery and the conductance demonstrates each 
ion channel. The equivalent circuit can be simplified in Thevenin 




Figure 1.8 Thevenin equivalent circuit of the model in figure 1.7 [9] 
 
Otherwise, ionic current of extra cellular space flows into cell and 
electrolyte. This can be modeled as current source is connected to 
series circuit of cytoplasm resistance and transmembrane circuit. 
Figure 1.9 demonstrates entire equivalent circuit for this situation.  
 
Figure 1.9 An equivalent circuit when current is applied from outside 
of cell.  
 
From this circuit model, change of transmembrane potential can be 
calculated in case of applying current pulse. Current applied to cell 
is given as equation 1.21, and if amplitude of current pulse is Ii, and 
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duration of current pulse is ti, change of transmembrane potential is 
derived as equation 1.22. Figure 1.10 demonstrates changes of 
transmembrane potential when current pulses applied cell 
membrane.  
 






Figure 1.10 Applied current pulses and corresponding changes of 
transmembrane potential [13]. 
 
1.1.3 Gating mechanisms of ion channels 
 
In former section explained that ion channel is modeled as a 
conductance in equivalent circuit modeling. Ion channel that passes 
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only specific ion is named as specific ion channel. And ion channel 
that passes ion regardless of ion kind is named as non-specific ion 
channel [12]. Also there are passive ion channels which are open 
always otherwise there are ion channels that have various gating 
mechanisms. These gating channels open and close its channel 
according to various stimulations applied on plasma membrane. Ion 
conductance and permeability of plasma membrane change 
according to gating of ion channel. From this, equivalent circuit of 
ion channel is demonstrated as variable conductance and battery. 
Furthermore, these gating channels which are activated by specific 
mechanism such as electrical stimulation allow the modulation of 
cellular processes. In this section, various gating mechanisms of 
active ion channels are demonstrated.  
 
 
Figure 1.11 Equivalent circuit of plasma membrane with reflection of 




1.1.3.1 Voltage-gated ion channel 
 
Voltage-gated ion channel closes when transmembrane potential 
maintains resting potential and opens when transmembrane 
potential change is occurred by hyperpolarization or depolarization 
as showed in figure 1.12. This channel is named by the type of 
passing ion for example of voltage-gated sodium channel, 
potassium channel, calcium channel and so on. In general, the gating 
of voltage gated ion channels is regulated by change of 
transmembrane potential, and it is affected by pH or condition of 




Figure 1.12 Schematic of gating mechanism of voltage gated ion 
channel [15] 
 




This channel is gated when specific ligand which acts as chemical 
messenger such as neurotransmitter binds to receptor protein of ion 
channel. Especially the channel which is gated by binding at 
extracellular surface is referred as ligand-gated. Also according to 
ligand material, the name of channel is determined. This channel 
reacts to ligand basically, and its gating is affected by channel 
blocker, ion concentration, membrane potential or enzyme. 
Representative types of this channel include nicotinic Ach receptor 
channel (nAchR channel), ionotropic glutamate receptor channel, 
ATP-gated P2X receptor channel, GABA receptor channel.  
This channel classified into three kinds of super family according to 
absence of evolutional relationship and each family has structural 
difference [12]. The family separated to Cys-loop receptor, 
ionotropic glutamate receptor and ATP-gated P2X receptor. Cys-
loop receptor channel is named by possession of a specific loop 
structure between amino acid of Cystein. This super family has five 
of sub-unit structure. The channels which are gated by 
neurotransmitter including serotonin, Ach, glycine, GABA belong to 
this super family. In contrast with Cys-loop receptor channel, 
glutamate receptor channel consists of four of sub-unit. This 
channel is activated by glutamate only. ATP-gated P2X receptor 
channel is activated by reaction with ATP and its sub-unit 
structure is not known as well. Figure 1.13 demonstrates schematic 





Figure 1.13 Schematic of gating mechanism of ligand-gated ion 
channel [16] 
 
1.1.3.3 Second messenger gated ion channel 
 
When primary transmitter receptor is activated by ligand such as 
neurotransmitter, intracellular second messenger is generated. 
Then second messenger gated ion channel is gated by 
corresponding second messenger.  This channel uses intra cellular 
ATP, PIP, G-protein, cAMP and cGMP as second messengers. 
Figure 1.14 is an example of this channel. This figure demonstrates 
ion channel gating mechanism of sea urchin sperm [17]. When 
ligand binds to guanylyl cyclase (GC), second messenger cGMP is 
generated. Then cGMP activated cyclic nucleotide gated potassium 
channel. Activation of potassium channel makes hyperpolarization of 
cell membrane. Otherwise cGMP undergoes hydrolysis by 
phosphodiesterase (PDE), then change into GMP. The GMP blocks 
action of GC. According to hyperpolarization of transmembrane 
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potential, hyperpolarization-activated and cyclic nucleotide-gated 
(HCN) sodium channel is activated. Intracellular cAMP participates 
to activation of HCN sodium channel also. Activated HCN sodium 
channel depolarizes membrane potential and drives to activate 
voltage-gated calcium channel. After activation of calcium channel, 
intracellular calcium concentration increases and cellular pathway is 
initialized. This cellular pathway modulates turning of sperm. After 
this event, intracellular calcium concentration is back to resting 
level by Ca2+/Na+ exchanger. In addition to this example there are 




Figure 1.14 Ion channel gating mechanism of sea urchin sperm [17] 
 
1.1.3.4 Mechanosensitive ion channel 
 
Every cell reacts to mechanical stimulation and transduces 
mechanical stimulation into electrical signal through 
mechanosensitive ion channel. Mechanosensitive channel is related 
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with not only hearing and touch but also various body function 
including blood pressure, cell swelling and musculoskeletal 
development. This channel has various types of structure, function 
and gating mechanism. Also every possible mechanism of signaling 
pathway that elicit electrical signal has been reported [18]. That is 
there is a channel which is regulated channel gating with membrane 
potential or agonist. Also there is a channel which gates ion flow 
directly or using second messenger. Table 1.2 shows family, its 
location and gating mechanism of representative mechanosensitive 
channels.  
Mechanosensitive ion channel has various kinds and structure, but 
they share important gating mechanism that the channel which 
consists of proteins is activated by mechanical stimulation and 
makes a pore of channel. Gating mechanism of mechanosensitive ion 
channel has following two models. 1) Lipid bilayer tension model 
(stretch model): In this model, plasma membrane changes its 
structure by lipid bilayer tension, then shape change of plasma 
membrane gates ion channel that embedded on plasma membrane. 
MSC family of bacteria uses this model typically [19]. 2) Tether 
model: In this channel, protein unit of mechanosensitive channel 
makes a direct connection to extra cellular matrix or cytoskeleton 
with chain structure. When external mechanical stimulation is 
occurred, a relative displacement between ion channel and extra 
cellular matrix or cytoskeleton is generated and this relative 
displacement regulated channel gating. Hair cell is a typical cell 
using this model [20]. Figure 1.15 demonstrates schematics of the 
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two models.  
 
Table 1.2 Family, location and gating mechanism of representative 





MscL bacteria lipid bilayer 
turgor regulation and cell 
growth 
MscS bacteria lipid bilayer 
turgor regulation and cell 
growth 
MscMJ archaea lipid bilayer turgor regulation 
MEC4 C. elegans tether touch 
TRPY fungi lipid bilayer turgor regulation 
TRECK-1 mammalian lipid bilayer resting membrane potential 











Figure 1.15 Schematics of two gating models of mechanosensitive ion 
channel [21] 
 
1.1.3.5 Light sensitive ion channel 
 
Channelrhodopsin is a representative light-sensitive ion channel. 
This ion channel is discovered in Chlamydomonas microalgae [22]. 
Channelrhodopsin is a sub family of rhodopsin. Rhodopsin is a visual 
pigment which lies on free-floating disc membrane inside of outer 
segment of a photoreceptor cell. This consists of a covalent 
complex of a large protein, opsin and a small ight-absorbing 
compound, retinal. According to type of rhodopsin, a wavelength of 
light absorbed by retinal is different. In opsin, a binding site exists 
for retinal, and the retinal fits snugly into the binding site of the 
opsin. When light stimulation is introduced, the retinal absorbs the 
light and undergoes molecular structural change. Then opsin cannot 
bind the retinal which is transformed by structural change and the 
released retinal initiates a cascade event which modulates 
membrane potential. The retinal stimulates a G-protein, and the 
stimulated G-protein activates a cGMP phosphodiesterase, then 
concentration of the cGMP in the photoreceptor cell decrease. The 
change of the cGMP concentration regulates a cGMP-gated ion 
channel, this ion channel participates depolarizing of membrane 
potential. This signal transfers to bipolar cell, ganglion cell and 
visual pathway [12]. While rhodopsin generates a second 
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messenger from light stimulation and regulates gating of ion channel, 
channelrhodopsin acts as an ion channel itself. Channel rhodopsin 
also has opsin and retinal structure. The retinal of rhodopsin binds 
and detaches to opsin, and the retinal of channel rhodopsin 
composes a pore of ion channel. The retinal of channelrhodopsin 
also absorbs different wavelength of light according to kind of 
channel. When the retinal of channelrhodopsin absorbs light of 
specific wavelength, the retinal undergoes conformational change. 
From this change, the ion channel is gated and membrane potential 
modulation is occurred. The conformational change of 
channelrhodopsin is very fast so the gating of channel is executed 
in several milliseconds. This channel acts as a non-specific ion 
Channelrhodopsin is sub familychannel. In figure 1.16, gating 






Figure 1.16 Gating mechanism of channelrhodopsin [22] 
 
1.1.3.6 Temperature sensitive ion channel 
 
Temperature sensitive ion channel is separated into a family of 
transient receptor potential (TRP) channel and non TRP channel 
[23]. In table 1.3, temperature sensing range, location and non-
thermal agonists of some representative temperature sensitive ion 





Table 1.3 Temperature sensing range, location and non-thermal 











acidic pH, resiniferatoxin, 














hypotonic, phorbol esters 
TRPM8 <25℃ PNS,  menthol, icilin, eucalyptol 
TRPA1 <17℃ PNS, hair cell 
cinnamaldehyde, mustard 
oil, 
allicin, icilin, etc. 





P2X3 warmth PNS ATP 
 
 
Gating of temperature sensitive channel is regulated by various 
agonists except temperature. Nevertheless membrane potential of 
cell participates to channel gating. There are two models of gating 
mechanism for this ion channel, one is 2-state model of Voets [25], 
 
 31
and another is 8-state model of Brauch [26]. Suggested common 
gating mechanism of two models is that difference of activation 
energy due to temperature change causes conformational change of 
channel and channel gating by second messenger. In two models, a 
membrane potential and temperature change are main variables of 
gating mechanism. There are no established gating mechanisms of 
temperature sensitive channel. There are many hypotheses 
regarding the mechanism of channel gating. The hypotheses 
includes that ion channel has a pore turret and this turret is gated 
by temperature or amino acid which is connected to channel acts 
gating lever, or denaturation of protein due to heat modulates gating.   
 
 
Figure 1.17 An example of gating mechanism of temperature 




1.1.4 Cellular processes generated by change of 
transmembrane potential 
 
Electrical stimulation generated from power supply device transfers 
electric charge through faradaic process and non-faradaic process 
at electrode/electrolyte interface. The charge is transferred in the 
form of ionic current to cell membrane. The electrical equivalent 
model of a plasma membrane helps to know that how does a 
membrane potential change according to ionic current. The change 
of transmembrane potential affects to cellular process modulation 
directly or indirectly. Especially the change of transmembrane 
potential from electrical stimulation modulates important cellular 
processes regulating the gating of voltage-gated ion channels. 
There are two important cellular processes which are regulated by 
voltage-gated ion channel - generation of action potential and 
triggering intracellular second messenger signaling pathway. 
 
1.1.4.1 Generation of action potential 
 
Action potential is a short-lasting event that membrane potential 
increase rapidly then decrease rapidly as like as shown in figure 
1.18 [28]. The action potential is generated in excitable cells only. 
The excitable cells that can generate action potential include neuron, 
muscle cell and endocrine cell [12]. The action potential takes an 
important role in cell to cell communication. When membrane 
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potential exceeds threshold potential, conductance change of 
voltage-gated ion channel is occurred. The action potential is 
generated by difference of transient change of ion channel 
conductance.  
 
Figure 1.18 Feature of action potential [28] 
 
As like as figure 1.19, voltage-gated ion channel can be modeled as 
a variable conductance. These conductances have a different 
tendency of conductance change when membrane potential exceed 
threshold potential. Figure 1.20 shows transient changes of ion 
conductance of each voltage-gated sodium channel and voltage-
gated potassium channel. Also action potential shape when 
membrane potential exceed threshold potential is demonstrated. 
When transmembrane potential of a cell is depolarized by external 
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electrical stimulation and exceed threshold potential, a voltage-
gated ion channel is activated. As shown in figure 1.20, the 
conductance change of voltage gated sodium channel is faster than 
the conductance change of a voltage gated potassium channel. 
Before activating of the potassium channel, a sodium ion channel is 
open and sodium ion current flows. This sodium current makes 
further depolarization of membrane potential. This relationship can 
be checked in Goldman’s equation. When a sodium ion channel is 
activated, sodium ion conductance increases and membrane 
potential is driven to Nernst potential of sodium ion. Then the 
membrane potential depolarizes continuously and finally the 
membrane potential changes to positive potential. After that, the 
sodium channel is close and sodium current decreases rapidly. Then 
the voltage-gated potassium channel lately gated makes potassium 
current. As the sodium conductance decrease rapidly and the 
potassium conductance increase rapidly, the potassium current 
drives the membrane potential as the Nernst potential of potassium 






Figure 1.19 Equivalent circuit model of cell membrane including 




Figure 1.20 Transient change of ionic conductance of voltage-gated 




1.1.4.2 Intracellular second messenger signaling 
pathway  
 
Voltage-gated ion channel is gated by membrane potential then a 
primary cellular process, intracellular second messenger signaling 
pathway is triggered. It appears through gating a channel with 
changing the membrane potential and that channel transports ion 
that triggers intracellular pathway. The representative second 
messenger which regulates intracellular pathway through voltage-
gated ion channel is a calcium ion. In resting state, the calcium ion 
concentration is very low about 100 nM compare to other ions. 
When the voltage-gated calcium channel is gated with membrane 
potential change, extracellular calcium flux into cytoplasm and 
secretion of calcium ion from intracellular calcium storage occurs. 
As a result intracellular calcium concentration increases by 100 
times, then a various cellular processes regulated including action 
potential generation, secretion, proliferation, cell swelling, 
differentiation, transcription and synaptic transmission [30]. Figure 
1.21 [31] demonstrates that intracellular calcium ion pathway 
cascade. With membrane potential increase the cell undergoes 
depolarization. Then the voltage-gated calcium channel is open and 
intracellular calcium concentration increases. The increased 
intracellular calcium binds intracellular ubiquitous calcium binding 
protein, calmodulin. The calmodulin bound with calcium activates 
serine/threonin phosphatase Calcineurin. The calcineurin 
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dephosphorylates transcription factor of NF-AT family, leads a 
translocation to cell nucleus. Then translocated NF-AT1 becomes a 
member of nuclear factor of activated T cell transcription. This 
complex roles primary action and the action involve gene 
transcription during immune reaction [32]. Furthermore the 
calmodulin with calcium activates calcium/calmodulin dependant 
protein kinase, CaMKI, CaMKII, CaMKIV and CaMKK. CaMKII and 
CaMKIV regulate gene transcription through several transcription 
factors including cAMP responsive element binding protein (CREB) 
[33]. Especially CREB is discovered its role for neuronal plasticity 
at brain and long-term memory formation [33]. CaMKI and 
CaMKIV phosphorylate Histone deacetylases (HDAC4, HDAC5, 





Figure 1.21 Intracellular calcium pathways [31] 
 
1.2 Bone regeneration using electrical stimulation  
 
1.2.1 Bone regeneration process by electrical 
stimulation 
 
In early 1950s, bone piezoelectricity was reported by Fukada and 
Yasuda [35]. Endogenous electric field is generated by bone 
piezoelectricity according to bone contraction or tension. And 
accompanying the existence of electric field bone formation or bone 
resorbsion occurs [36]. Based this phenomena, enhancing bone 
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healing by generating electric field to bone using electrical 
stimulation device became a basic idea of bone regeneration [37]. 
As mentioned in former section, electrical stimulation regulates 
cellular process through modulation of membrane potential. Bone 
cells also undergo a change of membrane potential by endogenous 
electric field or electric stimulation. The membrane potential change 
elicits regulation of cellular process related with electricity. Figure 
1.22 demonstrates activation of cellular process pathway through 
electrical stimulation. Moreover the membrane potential modulated 
by electrical stimulation activates a voltage-gated calcium channel, 
makes increase of intracellular calcium concentration. Increased 
calcium ion activates calcium/calmodulin pathway, then gene 
transcription in cell is modulated by calcium/calmodulin. Through 
this cascade event, many cellular processes occur. The regulated 
processes include increase expressions of BMP-2, BMP-4, TGF-
beta1, ALP and VEGF, strong formation of extra cellular matrix, 
arise of proliferation and differentiation of osteoblast cell, 
prohibiting bone function failure, encourage of acceleration of bone 
formation [38-40]. Also the increase of intra cellular calcium 
concentration affects bone formation through mineralization of bone 
cell followed calcium phosphate deposition to extracellular collagen 




Figure 1.22 Cellular pathways and cellular process regulated by 
electrical stimulation in osteoblast 
 
1.2.2 Clinical studies of bone regeneration using direct 
current stimulation  
 
There are two methods for deliver electrical stimulation to bone 
defect site. One is direct electrical stimulation and another is 
indirect electrical stimulation. In the method of direct stimulation, an 
electrode is placed to defect site. In the method of indirect 
stimulation, an electrode is not inserted into defect site. Instead of 
insertion of electrode, indirect stimulation method utilizes 
electromagnetic field which is generated a pair of electrode at the 
outside of skin.  Using direct current stimulation method, 
concentrated electrical stimulation to the defect site is possible. 
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This allows an effective stimulation with a small dose of electricity. 
Also acceleration of bone healing is feasible because cellular 
process modulation through electrical stimulation can be limited in 
the defect site. However the method of direct electrical stimulation, 
insertion of electrodes is inevitable. A surgery for insertion of 
electrode is necessary. Also there is a risk of infection or 
inflammation. In case of indirect electrical stimulation method, a 
relatively convenient administration of electrical stimulation is 
possible without surgery. But to deliver electrical stimulation, an 
external stimulator is required and this can disturb a compliance of 
patients. Also an effect of bone regeneration is hard to concentrate 
into defect site because other tissue is under the electrical 
stimulation not only the defect site. In this study, we would like to 
concentrate the method of direct current stimulation.  
Because an electrical stimulation has a good osteoinductive 
property, there were many clinical trials to achieve rapid healing of 
bone fracture using electrical stimulation. In 1971 Friedenburg 
inserted a stainless steel wire into defect site with delivery of 10 
μA electrical stimulation to treat nonunion of the medial malleolus 
and reported the electrical stimulation was effective for the healing 
of nonunion [42]. This is the first clinical study that administrated 
direct electrical stimulation to the defect site and reported bone 
regeneration. After in 1974 Dwyer used electrical stimulation to 
healing of spinal fusion and reported bone formation [43]. In 1975 
Brighton reported the healing of long bone nonunion [44] and in 
1977 Torben reported enhancement of bone formation in case of 
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tibial nonunion using electrical stimulation [45]. In 1977 Lavine 
used an electrical stimulation to congenital pseudoarthrosis and 
commented that a combination treatment of bone graft and electrical 
stimulation would promote bone regeneration [46]. From these 
early clinical trials the direct current stimulation method is utilized 
in treatment of spinal fusion, bone fracture, long bone nonunion, 
congenital pseudoarthrosis and avascular necrosis [47-50]. 
Although there are some reports that electrical stimulation was not 
effective to treat bone defect, but many researchers reported that 
electrical stimulation promote bone healing. Also Brighton tried to 
find proper electrical stimulation dose through animal and clinical 
studies and suggested the 20 μA of electrical stimulation is 
effective to promote bone regeneration [51]. Steinberg suggested a 
necessary of detailed prediagnosis for bone healing using electrical 
stimulation [52]. The acceleration of bone regeneration and 
promotion of bone healing through electrical stimulation is varying 
according to age of patients, shape of bone defect, parameters of 
stimulation. However electrical stimulation is considered as a highly 
osteoinductive tool and related studies are reported continuously.  
 
 
1.2.3 Development progress of direct current 
stimulator for bone regeneration  
 
An early device for direct current stimulation to the bone defect 
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consisted of a power supply and wire or rod shaped electrode which 
was connected to the power supply. Figure 1.23 shows an early 
device that was used in the animal study of rabbit tibial nonunion 
healing in 1970s [53].  
 
 
Figure 1.23 An early direct current stimulator for bone regeneration  
 
There are three kinds of major limitations which can be observed 
from the early electrical stimulation. First is a percutaneous 
electrode. These electrodes were inserted into the defect site for 
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treatment. And there was a risk of infection due to exposure of 
electrode or electrode connection line through a skin. Second is a 
difficult control of electrical stimulation parameters. The electrodes 
were connected to battery directly. According to electrode status, a 
control of delivered current was difficult. Also the early device used 
a constant DC. If constant DC is delivered continuously, Faradaic 
products due to charge accumulation produced. These products 
change local pH and it may cause cell damage. And constant DC 
accumulates protein to charged electrode. The protein accumulation 
changes an electrode property, so maintenance of effective 
electrical stimulation parameter is difficult. Third, a limitation of an 
effective area comes from electrode shape. The effective area of a 
wire or a rod shaped electrode is known as 5~8 mm of the 
electrode surrounding [54]. This means that only a defect area 
which is located in a certain distance from the electrode receives 
regeneration effect from electrical stimulation. So if the defect area 
is formed beyond the effective stimulation area of electrode, bone 
regeneration effect is limited. It is necessary that an usage of 
electrode that adjust to the shape of the defect area for 
concentrated treatment of electrical stimulation.  
The early stage of electrical devices for bone regeneration which 
has limitations as mentioned above were improved gradually, 
nowadays there are various devices developed and commercialized. 
Table 1.4 lists up bone regeneration devices using electrical 
stimulation approved from FDA, these devices is utilized to 
treatment various bone defects including non-union fracture, spinal 
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fusion and osteoporosis.  
 
Table 1.4 FDA approved conventional bone regeneration devices 
using electrical stimulation [37] 
 
 
The improved features of three major limitations of the early 
devices are as in the following. First, a design of electrical 
stimulation device which had a percutaneous wire or rod was 
changed into an implantable device. The first implantable device 
was used by Paterson in 1984 for treatment of congenital 
pseudarthrosis of tibia [55]. The implantable stimulation device 
does not make any exposed electrode or connection line so risk of 
infection due to percutaneous electrode can be removed. Also the 
implantable device has minimal postoperative discomfort. For 
implantation the device was miniaturized and had hermeticity. The 
device power was supplied by battery so the device size depends 
on battery size. Also a stimulation period is limited. Second, the 
device generated electrical stimulation by programmable current 
generation chip. Using a current source uniform current stimulation 
was possible regardless of electrode status. Also to avoid issues 
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from constant DC stimulation, biphasic electrical current (BEC) is 
using. BEC can avoid charge accumulation and has an effective for 
bone formation and growth factor recruiting. Third, a wavy wire or 
mesh electrode was developed to apply in various shapes of bone 
defect. These electrodes can transform its geometrical shape so 
that closer and wider contact to defect site is achievable. OsteoGen 
device of Biomet in figure 1.24 has improvements mentioned above 
[56]. In this device a current stimulator is packaged with titanium 
and silicone rubber. Implantable period is 6 months and during the 
period the device is powered by battery imbedded in titanium 
package. This device uses a pair or many pairs of titanium wavy 
electrode for electrical stimulation. By a wavy electrode the contact 
area between the electrode and defect site increases. This device 
can be applied for treatment of bone defect such as nonunion 
fracture, and fixation of bone grafts. Although this device improved 
some limitations of the early device, there are other limitations. 
First, this device used its titanium package as anode. In this case 
electrical stimulation is not restricted in the area of bone defect, so 
the effect of electrical stimulation is distributed to other tissue. 
Second, although wavy or mesh electrode has an advantage to treat 
bone fracture or nonunion, it is not proper to bone grafting or spinal 
fusion which need three dimensional delivery of electrical 
stimulation. Third, after bone healing, the package should be 
subtracted so two surgical procedure is necessary. Fourth, after 
implantation, change of stimulation parameter is impassible. Fifth, 





Figure 1.24 Bone regeneration device of Biomet and schematic of 
application of the device to bone fracture 
 
1.3 Bone regeneration therapy  
 
1.3.1 Existing bone regeneration therapies 
 
Although bone tissue is capable of self-regeneration, if defect site 
is over critical size, it is difficult to regenerate by oneself. Also it 
takes long period to heal and even though after recovery, it is 
possible to acquire bone structural disorder such as non-union. 
Therefore a proper therapy is necessary to make rapid healing of 
bone defect. For the existing bone regeneration therapies to treat 
bone defect, block grafting, distraction osteogenesis and bone 
splitting are executed [57]. Block grafting is a surgical procedure 
that transplants a bone graft to bone defect site. Autograft is the 
most preferred because the graft is harvested from the patient’s 
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own body so there is less risk of infection or immune reaction 
compare with other graft [58]. Grafts are harvested from intra, 
extra oral, iliac creat, finula, mandible and skull usually. However to 
harvest autograft, additional surgery should be conducted from the 
patient who already have bone fracture. Also the volume of harvest 
is limited. Distraction osteogenesis (DO) is a surgical procedure 
that utilizes a self-repair character of bone. This is used in 
reconstruction of skeletal deformities or bone increase [59]. In this 
procedure, a target bone is split into two pieces using corticotomy, 
and the end of divided bones is drawn gradually. Then a gap 
generated between the bones is filled with new bone by self-repair 
of bone. Through this process the construction and bone healing 
occurs. The period of pulling a bone is called to be a distraction 
phase. Then if a sufficient increase and reconstruction of bone is 
achieved, consolidation period follows. This procedure takes an 
advantage that surround soft tissue grows simultaneously with bone 
grow. But a possible procedure region is limited and it is hard to 
conduct in case of a large bone defect. In bone splitting, a bone is 
split using a rotating instrument or ultrasonic device. After bone 
spitting, distraction of bone using osteotome follows. Then an 
implant is inserted to split bone and filled with autologous bone or 
replacement material. This procedure is difficult to conduct if a 





1.3.2 Bone regeneration therapy using stem cell graft 
 
In case of more than 1 cm of bone defect, bone regeneration relies 
on bone graft transplantation such as block grafting [61]. In addition 
of bone graft transplantation using autograft, allograft or xenograft, 
a bone regeneration therapy using stem cell graft is introduced with 
development of tissue engineering, and the stem cell grafting is 
conducted successfully. The bone regeneration therapy using stem 
cell graft utilizes a method of tissue engineering in bone repair. A 
graft seeded stem cells is implanted into bone defect area and the 
stem cell in graft is ossificated into bone tissue. As important 
components in stem cell grafting, there are osteoblast cell will be 
differentiated to bone cell and morphological signals that makes 
stem cell differentiation [62]. For the cell used in stem cell grafting, 
autologous cell is considered as a golden rule. But there are some 
restriction that their limited available cell amount and additional 
surgery for harvesting. Therefore the usage of stem cell is 
increased for bone graft because stem cell has a pluripotency and a 
large amount of stem cell can be harvested by cell culture. After 
harvest from donor, the stem cells are cultivated at in vitro 
circumstance by incubator. After the cells are proliferated 
sufficiently, they are inoculated to a biodegradable material which 
has a porous structure such as collagen sponge or hydrogel for cell 
adhesion. Finally the cell graft is transplanted into bone defect site. 
The stem cell graft should be set into a proper structure to be 
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protected from external damage and to be fixed in defect site. The 
structure that acts containment system for stem cell graft is made 
by biodegradable material or titanium mesh that has a high 
osteointegrity [63]. Morphological signals applied to stem cell to 
make differentiate into bone cell are important in bone graft 
transplantation procedure. As the signals that induce bone 
differentiation, mechanical stimulation like repetition of shear stress, 
ultrasonic, heat and infrared light are known [64]. Also bone 
differentiation is mediated by injection or activation of bone 
morphogenetic protein (BMP) -2, 4, 7 or transforming growth 
factor beta (TGF-β) [65]. It is necessary for a successful 
application of bone graft transplantation that a proper apply of two 
important factors, osteoblast cell and morphogenetic signals.  
Especially in the case of osteoblast cell, the expansion of cell 
numbers by in vitro cell culturing is required. For cell expansion, 
more than a month of long period is required. Consequently there 
are disadvantages of high cost, infection risk, and low cell viability 
due to the cell culture procedure [66]. Therefore for apply the stem 
cell graft transplantation procedure and successful bone 
regeneration, it is important that harvesting more viable cell and 
more amount of cell [66].  
 
1.4 LCP as bone substitute 
 
Liquid crystal polymer (LCP) is a kind of aromatic polyester. It has 
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very low water absorption rate, inert chemical reaction property, 
excellent mechanical property, and biocompatibility [67]. Figure 
1.25 shows the crystal unit structure of LCP. A solid monomer and 
soft monomer is arranged as consistence in aqueous status.  
 
 
Figure 1.25 Crystal unit structure of LCP 
 
LCP is thermoplastic polymer. It can be deformed into various 
shapes in high temperature. Also LCP can be adjust in semi-
conductor process. A film type LCP can be made in multi-layer 
structure. From these characteristics of LCP, active studies of LCP 
as a package material for neural prosthetic device and a substrate 
material of electrode [68-70]. Furthermore LCP is a material that 
has a high osteointegrity, it is studied as bone substitute material 
[71]. 
Kettunen et al. designed LCP in shape of a rod and drilled a femur 
of rabbit and dog. Then they inserted the LCP rod to bone defect 
and examined bone adhesion and implant failure after 1 year of 
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follow up for rabbit and 4 years of follow up for dog. After 
examination, they obtained a sufficient stability in fixation. There 
were no evidence of tissue reaction and no sign of implant failure 
both of rabbit and dog [71-72]. 
 
1.5 Objectives of the dissertation  
 
As an excellent osteoinductive signal, electrical stimulation has a 
positive effect on bone regeneration. The conventional bone 
regeneration devices using electrical stimulation is used for bone 
repair and regeneration. However the conventional device is not 
proper to apply in bone graft transplantation for the case of large 
bone defect. It is necessary for application of bone grafting using 
electrical stimulation that electrical stimulation should be delivered 
the entire of bone graft that has three-dimensional area effectively. 
The electrode of the conventional device is wire shape and the 
electrical stimulation is delivered to around of the wire electrode 
only so it cannot deliver electrical stimulation to three-dimensional 
bone graft. To apply electrical stimulation into bone grafting, the 
shape of electrode is a structure can contain the bone graft for 
delivering electrical stimulation to entire of the bone graft. In this 
dissertation, development of bone regeneration device that 
accelerate bone formation by stimulating electric current pulses 
which have high osteoinductive property for bone graft 
transplantation procedure that conducted in the case of large bone 
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defect is demonstrated. Also the evaluation of bone regeneration 
using the device is reported. To achieve these objects it is required 
several steps. First is a development of a device that can deliver 
electrical stimulation to stem cell graft at in vivo circumstance. 
Using the device cell proliferation and up-regulation of cell viability 
will be reported. For the next step, a development of bone 
regeneration device using electrical stimulation for targeting a 
rabbit mandibular defect model by improvement of cell culture 
device developed before. Using this device, tissue engineered bone 
regeneration with combined treatment of electrical stimulation and 
growth factor will be conducted. For the last, by improving former 
device, LCP-based bone regeneration device will be designed. 
Through this device, the concept of fully implantable, battery-less, 






Chapter 2 Materials and Methods 
 
2.1 Implantable bioreactor device  
 
2.1.1 Device configuration 
 
Implantable bioreactor device consists of three components. First is 
a bioreactor chamber. A stem cell graft which is cultivated 
intracorporeally and electrode which delivers electrical stimulation 
to the cell graft are set into the bioreactor chamber. The bioreactor 
should be made with a biocompatible material because it will be 
implanted in the body. Also the chamber should have proper shape 
and size for relevant to the experimental animal. And the chamber 
should be designed as the chamber allows interaction of body fluid 






Figure 2.1 Design of the bioreactor chamber  
 
We designed the chamber in the form of a cylinder using Teflon 
which has a biocompatibility. The length of the chamber is 15~17 
mm according to electrode type. The size of the holes was 300μm 
in diameter along the surface of the wall of the chamber to allow 
interaction of body fluid and nutrition into the inside of the chamber. 
The second component of the bioreactor device is a current 
generator chip. This stimulation chip was produced by Intergration 
circuit design education center (IDEC) 80th Samsung 0.18 μm 
process and the circuit configuration is same as our previous 
stimulation chip [73 Electrical stimulation type produced by 
stimulation chip is charge-balanced biphasic electric current pulse. 
The parameters of BEC can be selected the amplitude from 2 μA to 
300 μA in 2-μA steps, the duration and the frequency from 16 μs to 
512 μs in 16-μs steps and from 32 Hz to 1 kHz in 32-Hz steps 
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respectively by attaching external components on the chip PCB.  
This chip is bonded to PCB which has 16 mm diameter by wire 
bonding. Then epoxy is covered the chip to protect from external 
shock. The stimulation parameter setting is conducted by external 
component assembled together and switch selection is executed by 
soldering. Figure 2.2 shows the feature of the bonded stimulation 
chip on the PCB with external components.  
 
 
Figure 2.2 Feature of the stimulation chip bonded on the PCB  
 
The current generator chip assembled on the PCB is supplied a 
power by a button style battery which is connected through wire. 
The battery for power supply can be selected in various types 
according to parameters of the electrical stimulation. Also the entire 
device is implanted in a body so the current generator chip should 
be hermetic packaged to prevent a failure of the device. In this 
study, silicone elastomer (NUSIL, MED-6215) is used as a 
package material. The package process is conducted with package 
molds which are made by acryl. Figure 2.3 shows three types of 
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Figure 2.3 Three types of packaging molds used in current generator 





Using the packaging molds, production of six packages of current 
generator chip is possible at once. The size of the sealing package 
differs according to type of battery. The process of packaging 
follows. First, adequate amount of silicone elastomer and hardening 
agent is taken in a ratio 10:1 respectively. They are mixed well 
then air is removed from the mixture using a centrifuge. After that, 
the mixture is taken by 3 ml through a disposable syringe. Then 
additional air removal using vacuum chamber is conducted. By these 
processes, it can be achieved that elimination of vacancy due to 
bubbles in the finally sealed package. The vacancy from bubbles 
makes main passages for infiltration of body fluid into the 
stimulation chip. So the vacancy is the cause that makes device 
failure, the air removal process is necessary for packaging with 
silicone elastomer. After air removal, mold A is covered with mold 
B and they are fixed with bolts. Then mixture of silicone elastomer 
is casted in the molds through the disposable syringe containing the 
mixture. After that a curing process is conducted for 30 min in the 
temperature of 90 degree. After curing, mold B is separated from 
mold A. Through this process the elastomer is made in a shape of 
dish. Then the current generator chip which is connected to 
electrode and battery is put on the elastomer dish, and mold C 
covers mold A and fixed with bolts. Then second silicone elastomer 
casting in the molds through the disposable syringe containing the 
mixture is conducted. Then curing step follows. Because a battery 
is cured together, the curing temperature should not be over to 45 
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degree. After 10 hours of curing, the packaged current generator 
chip is separated from mold. The packaged device has a shape of 
thick coin which diameter is 20 mm and thickness is 4 mm in case 
of using 1620 battery. The package can protect a device failure due 
to infiltration of body fluid for a month of an implantation period. In 
figure 2.4, the packaged current stimulation ship and battery with 
silicone elastomer is shown.  
 
 
Figure 2.4 A feature of the packaged PCB with silicone elastomer  
 
The last component of bioreactor is an electrode which delivers 
electrical stimulation to the stem cell graft inside of the bioreactor 
chamber. The package volume of the current stimulation chip is as 
large as the bioreactor chamber, so if the chamber and chip package 
are implanted into same area together, it may cause hindrance of 
animal movement and pain due to large volume of implant body. 
This can cause an unexpected effect to the results. So the electrode 
should have a sufficient length of connection line to allow the 
current stimulation chip and the bioreactor chamber is implanted 
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with making an adequate distance. This connection line should have 
a flexibility and biocompatibility. Also it should have to achieve 
convenience for surgery and to eliminate hindrance of animal 
movement. Combining three components, it is possible to make an 
implantable bioreactor device. And using this device, intracorporeal 
cell culture is possible through setting cell graft into the chamber at 
in vivo circumstance.  
  
2.1.2 Bioreactor using titanium electrode 
 




Figure 2.5 A schematic of bioreactor that uses titanium electrode 
 
Titanium electrode consists of a pair of volt and nut which were 
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made by titanium. The head of the volt is circular shape and outer 
diameter of volt is 8 mm and inner diameter is 6 mm. The length of 
volt head is 1 mm, the entire length of volt is 4 mm. The shape of 
nut is circle and its outer diameter is 8 mm and its inner diameter is 
6 mm. This electrode pair is connected to PCB of current generator 
chip through a tungsten wire which has a diameter of 100 μm and a 
length of 100 mm. The tungsten wire is fixed in joint of the volt and 
nut. For titanium electrode, the bioreactor chamber was designed in 
a form of cylinder which has a length of 15mm, diameter of 8mm 
using Teflon. The chamber was designed as a hollow cylinder and 
titanium electrodes were inserted into the both end of the chamber. 
In the case of titanium electrode, a current path is generated in the 
direction of the longitudinal direction of the chamber. Figure 2.6 
shows a designed bioreactor chamber and titanium electrode and 
figure 2.7 demonstrated the entire feature of bioreactor system 
with titanium electrode.  
 
 





Figure 2.7 The entire feature of bioreactor using titanium electrode 
 
2.1.3 Bioreactor using polyimide electrode 
 




Figure 2.8 A schematic of the bioreactor using a polyimide electrode  
 
Electrode was designed using biocompatible, flexible polyimide. 
Polyimide has been generally used as an electrode substrate 
material of various neural prosthesis devices [63]. The electrode 
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part and connection line of the polyimide electrode were made by 
polyimide also, and the electrode site and conductor of connection 





Figure 2.9 Electrode part of the polyimide electrode 
 
This electrode part put into the bioreactor was a 15 mm square 
shape, and had two rectangular shaped gold patterns of which length 
was 12 mm and width was 3 mm. And except the area of gold 
patterns, electrode area was evenly holed sizing 300 μm in a 
diameter. The two gold patterns were placed face to face when the 






Figure 2.10 The setting of polyimide electrode into the bioreactor 
chamber  
 
Total length of the connection line of the polyimide electrode was 
100 mm and the width was 5 mm. This connection line was 
connected to PCB of current stimulator chip. Chamber, where the 
electrode is inserted into, was designed in a form of cylinder which 
has a length of 17mm, diameter of 8mm using Teflon. It is designed 
as one side blocked cylinder and has a Teflon cap to block other 
side after put into the stimulation electrode and scaffold. In the case 
of polyimide electrode a current path is generated in the direction of 
the center of the chamber. Figure 2.11 shows the bioreactors which 





Figure 2.11 The entire feature of bioreactor using polyimide 
electrode  
 
2.1.4 In vivo cell proliferation experiment 
 
The process of in vivo cell proliferation experiment follows. First 
stem cell was inoculated on collagen sponge. Then the collagen 
sponge was set into bioreactor device and the bioreactor which 
contains stem cell graft was implanted into a rat. After 2 weeks of 
surgery, the cell graft was harvested and the cell proliferation and 
cell viability were evaluated.  
 
2.1.4.1 Preparation of collagen sponge 
 
Type I atelocollagen powder (Bioland, Korea) was dissolved in 
0.001 N HCl at a concentration of 20 mg/ml, and CS (Sigma 
Chemical Company, St. Louis, MO) was dissolved at a concentration 
of 2 mg/ml. The collagen-CS solution was poured into a 60 mm 
dish and was lyophilized by freeze-drying (Samwon Freezing 
Engineering Co., Korea) at -80°C for 48 h. The collagen sponge 
was incubated in 20 ml of 40% (v/v) ethanol containing 50 mM 2-
morpholineoethane sulfonic acid (MES, Fluka Chemic AG) (pH 5.5) 
for 30 min at room temperature. The collagen sponge was 
immersed in 20 ml of 40% (v/v) ethanol containing 50 mM MES (pH 
5.5), 24 mM 1-ethyl-3-(3-dimethyl aminopropyl)carbodiimide 
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(Fluka Chemic AG), and 5 mM N-hydroxysuccinimide (Fluka 
Chemic AG) for 12 h at room temperature. Once the reaction was 
complete, the collagen sponge was washed twice in 0.1 M Na2HPO4 
(pH 9.0) for 12 h. The scaffolds were then washed twice in 1M 
NaCl for 6 h, then in 2 M NaCl for two days. Finally, the sponges 
were rinsed with distilled water. The collagen sponges were 
lyophilized by freeze-drying and were cut by the shape of circle 
that has a diameter of 5 mm and a thickness of 1 mm and then 
sterilized with γ-irradiation at 15 KGy. The collagen sponge has 
average ultimate tensile strength of 1.5–0.05 MPa, and compressive 
moduli of 1.80 ~ 17.29 kPa with a loose network of collagen fibrils 
and an approximate pore size of 80~150 µm. 
 
2.1.4.2 Preparation of hMSCs 
 
The commercial hMSCs (Lonza, Walkersville, MD) derived from 
bone marrow were cultured in a specific culture medium provided 
from the maintenance company under a humidified atmosphere of 
5% CO2 at 37°C. The hMSCs were inoculated onto a collagen 
sponge. After approximately 3-h of incubation, high-glucose 
Dulbecco’s modified Eagle’s medium supplemented with 10% 
heat-inactivated fetal bovine serum was added to the cells. The 
next day, cells seeded on a collagen sponge were placed inside the 
bioreactor and exposed to an electric field formed by the flow of 
current from the bioreactor. 
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2.1.4.3 Process of animal experiment 
 
Every in vivo experiment was performed in accordance with the 
“Recommendations for Handling Regulation for Laboratory Animals 
for Biomedical Research” compiled by the Committee on the Safety 
and Ethical Handling Regulation for Laboratory Experiments in the 
School of Dentistry at Seoul National University. Male SD rats (6 
week, n=4) were used in every in vivo experiments. After 
anesthesia, the both side of the thigh of the animal was incised, the 
bioreactor chamber that contains stem cell graft was placed in the 
upper thigh. And the package of stimulator was placed in the lower 
thigh. The animal was then sutured. The single type of electrode 
was used in one animal, and each animal has two bioreactor 
chambers in the body but electrical stimulation was delivered in 
only one bioreactor chamber. Electrical stimulation was delivered in 
the form of charge-balanced biphasic current pulses at an 
amplitude of 20 μA, a duration of 100 μs, and a frequency of 100 Hz. 
After the surgery, electrical stimulation was performed for 1 week. 
And the cell culture period was 2 weeks. After cell culture period, 
the animal was sacrificed, the bioreactor and collagen sponge were 
extracted, and a quantitative evaluation of cell proliferation was 
conducted using a MTT assay. Figure 2.12 shows entire process of 










2.1.5 Assessment of cell proliferation 
 
2.1.5.1 MTT assay 
 
The proliferation of cells cultured on a collagen sponge in vitro or in 
vivo was assessed at 2 or 4 days using a the Cell Counting Kit-8 
(Dojindo Laboratories), which employs tetrazolium salt, WST-8 
[2-(2-methoxy-4-nitrophenyl)-3-(4-nitrophenyl)-5-(2,4-
disulfophenyl)-2H-tetrazolium, monosodium salt]. Processes were 
carried out according to the manufacturer’s protocol. The amount 
of yellow-colored product was measured at a wavelength of 450 
nm using a microplate reader and was directly proportional to the 
number of viable cells in the culture media. The optical density 
(OD) values of samples represent the index of cell proliferation. 
This assay was repeated for three or four independent samples (n 
= 3-4). 
 
2.1.5.2 Scanning electron microscopy (SEM) 
 
The sponges were washed twice with PBS. Cells adhering to the 
sponges were fixed with 2.5% glutaraldehyde. After washing thrice 
with PBS, the adhered cells were dehydrated in an ethanol-graded 
series and allowed to dry on a clean bench at room temperature. 
The sponges were then coated via the Au-Pd sputtering method. 
SEM observations were conducted with a Hitachi s-4700 field 
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emission SEM at 30 kV. 
2.1.5.3 Reverse transcription=polymerase chain 
reaction (RT-PCR) 
 
The collagen sponge with hMSCs was washed with PBS solution and 
chopped into small pieces. After adding 0.5 mL of TRIzol reagent 
(Invitrogen, Life Technologies) directly to the chopped sponge, the 
total RNA was extracted and then subsequently treated as 
prescribed in the manufacturer’s instructions. The total RNA was 
extracted by adding 0.5 mL of TRIzol reagent (Invitrogen, Life 
Technologies) directly to the chopped sponge. One microgram of 
RNA from each sample was subjected to cDNA synthesis using 
SuperScriptTM Reverse Transcriptase II (Invitrogen) and oligo 
(dT)12–18 primer (Invitrogen) in a 20 mL reaction volume 
according to the manufacturer’s instructions, and RNA 
complementary to the cDNA was removed using E. coli RNase H 
(Invitrogen). One microliter of cDNA was then subjected to a 
polymerase chain reaction using the following amplification profile: 
predenaturation at 94 C for 40 s, amplification (denaturation at 
94°C for 40 s; annealing at 60°C for 40 s; an extension at 72°C 
for 1 min) for 30 cycles, followed by a final extension step at 72°C 
for 10 min. PCR was performed in a DNA thermal cycler (model 
PTC-200; MJ Research, Inc.). Ten microliters of each of the PCR 
product were electrophoresed on 1.5 % agarose gel in the presence 
of ethidium bromide, and the bands were visualized using a Gel 
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Documentation System (Vilber Lourmat). The human primer 
sequences were as follows: type I collagen (GenBank# BC036531) 
forward, CGA AGA CAT CCC ACC AAT CAC; reverse, CAG ATC 
ACG TCA TCG CAC AAC; β-actin (GenBank# BC004251): 
forward, ATT GCC GAC AGG ATG CAG AAG; and reverse, TTG 
CTG ATC CAC ATC TGC TGG. 
 
2.2 Implantable electrical stimulation device for bone 
regeneration 
 
2.2.1 Configuration of bone regeneration device 
 
The implantable electrical stimulation device for bone regeneration 
was designed by improving the implantable bioreactor device 
developed before. Figure 2.13 demonstrated the designed bone 
regeneration device.  
 




The bone regeneration device was composed with two components 
of electrical stimulator and electrode which can contain a stem cell 
graft. The current generator chip, PCB, and battery used in bone 
regeneration device were same as in the bioreactor device. Also the 
package material and method were identical with the case of 
bioreactor. The flexible polyimide electrode of this device can 
effectively deliver electrical stimulation to local three-dimensional 
tissue area by changing the shape of the electrode fitting to the 
target tissue. Also by applying a containment system made with 
biodegradable material or high osseointegrative material such as 
titanium, in vivo bioreactor circumstance with electrical stimulation 
can be set in the body. Therefore stem cell grafting with electrical 
stimulation is possible by setting the cell graft into bioreactor 
circumstance which is made by the combination of electrode and 
containment system. Furthermore through scaffold material or 
external treatment, injection or secretion of growth factor which 
helps cell proliferation or differentiation is possible.  
 
2.2.2 Electrode for bone regeneration of rabbit 
mandible  
 
Using polyimide as the electrode substrate material, we designed an 
electrode that was feasible for local stimulation of a three 
dimensional bone scaffold. A pair of gold electrodes 5 mm in width 
and 10 mm in length was patterned by electroplating onto the 
 
 73
polyimide substrate which was 20 mm in width and 12 mm in length. 
The pair of gold electrodes was 8 mm apart from each other. After 
electroplating, a non-patterned section of the polyimide substrate 6 
mm in width and 9 mm in length between the pair of gold electrodes 
was cut off. The two gold electrode sites were placed face to face 
when the section of the gold electrode site was folded at 90 
degrees. The electrode could then be set into the PCL outer box. In 
the PCL outer box, electrical stimulation was delivered to hBMSCs 
on a collagen carrier between the two gold electrode sites. Also, the 
polyimide electrode had a 10 cm polyimide connection line. Through 
this line, the electrode and stimulation chip were connected and the 
electrical stimulation was delivered. The connection line allowed the 
stimulation chip to be implanted onto a part that was distanced from 
the defect site.  
 
2.2.3 Preparation of collagen sponge 
 
A collagen sponge was prepared from the cross-reaction of type I 
collagen (Bioland Co.) and chondroitin-6-sulfate (Sigma Chemical 
Company, St. Louis, MO, USA) as previously described section. The 
shape of prepared collagen sponge is 13 mm x 6 mm of rectangular 
shape that has a thickness of 1 mm.  
 




Commercial hBMSCs (Lonza, Walkersville, MD) derived from bone 
marrow were cultured in a specific culture medium provided by a 
maintenance company under a humidified atmosphere of 5% CO2 at 
37°C. The hBMSCs were inoculated onto the collagen sponge (1 x 
105/sponge).  
 
2.2.5 Preparation of hydrogel 
 
Hyaluronic acid (HA) (0.25 mmol, MW 23 kDa, Lifecore, USA) was 
dissolved in 40 ml of distilled water and 1-Ethyl-3-(3-
dimethylaminopropyl)-carbodiimide (EDC, 0.24 g, 1.25 mmol, 
Sigma-Aldrich, USA), 1-hydroxybenzotriazole hydrate (HOBT, 
0.17 g, 1.25 mmol, Fluka, Switzerland) and adipic acid dihydrazide 
(ADH, 2.2 g, 12.5 mmol) were added to the solution [75]. The 
EDC-mediated the coupling reaction between the carboxyl group of 
HA and the hydrazide group of ADH continued, with stirring, at 
room temperature for 8 h. HA–ADH was dialyzed against 100mM 
NaCl for 2.5 days and distilled water for 1 day using a dialysis 
membrane (MWCO 14,000, SpectraPor, USA). N-
acryloxysuccinimide (NAS, 0.5 g, 3 mmol, Polyscience, USA) was 
subsequently added to the HA–ADH solution. The reaction 
continued, with stirring, at room temperature for 12 h. HA–ADH–
NAS was dialyzed extensively against 100mM NaCl for 2.5 days 
and distilled water for 1 day. The product was then lyophilized for 3 
days to obtain solid acrylated HA (HA-Ac). For the preparation of 
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the gel, MMP-sensitive peptides (GCRDGPQGIWGQDRCG, AnyGen, 
Korea) were added to the acrylated HA solution [75] with the same 
molar ratio of acryl and thiol groups. The HA-based hydrogel was 
formed via a Michael-type addition reaction [75] Cell-adhesion 
peptides (RGDSP, AnyGen, Korea) were also immobilized on the 
acrylated HAS with a molar ratio of 20% of the acryl groups of the 
HA. The reaction mixture, carrier-free rhBMP-2 (5μg, R & D 
Systems, USA) and the collagen sponge seeded with the hBMSCs 
were incubated at 37°C for gelation. These HA-based hydrogels 
with the collagen sponge were set into the PCL outer box and 
implanted into the rabbit mandible defect site as bone substitutes. 
 
2.2.6 Preparation of PCL containment system  
 
The outer box as a containment system, which creates a space for 
the hydrogel, stem cells, and the electrical stimulation device, was 
positioned at the rabbit mandibular defect. It was composed of four 
walls: the buccal, lingual, lower and upper walls. The upper wall 
prevented new bone ingrowth into the bone defect space from 
residual alveolar bone, and the right and left sides were open, 
though they were closed by neighboring bone surfaces at the bone 
defect area (7 x 7 x 15mm), and new bone ingrowth into bone 
defect space was allowed. The outer box was prepared using 
polycaprolactone (PCL) (average MW ~42,500, Sigma-Aldrich, St. 
Louis, MO) which was softened in hot water (60 ℃). It was built by 
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bonding four plates (8 (W) x 15 (L) x 1 mm (T)) of PCL with a hot 
spatula. Numerous pores (1 mm in diameter) were formed for blood 
and nutrition flows through the walls of the PCL plates using a 
dental fissure bur (Mani, Inc., Japan) before fabricating the box. 
The PCL outer box was then coated with calcium phosphate 
crystals to improve cell adhesion using modified methods described 
in previous reports [76]. After the sterilization of the PCL outer 
box using gamma irradiation, the electrode of the electrical 
stimulation device, the hydrogel and the collagen sponge seeded 
with the hBMSCs were set into the PCL outer boxes. The PCL outer 
boxes were then implanted into the rabbit mandibular defect sites. 
  
2.2.7 Animal experiment 
 
2.2.7.1 Animal experiment configuration 
 
Male New Zealand white rabbits (n=5, 3~3.5kg) were used. The 
bone defect is given into intra sub-mandibular area of the rabbit 
and the complex bone regeneration system which is composed with 
PCL outer box, collagen sponge with stem cell, hydrogel containing 
rhBMP-2, and electrode of bone regeneration device is implanted 
into the defect site. The used electrical stimulation parameter is 
follows; amplitude of 20 μA, duration of 100μs, frequency of 100 
Hz, charge-balanced biphasic current (BEC) pulses, period of 7 
days. And the experimental group is divided into three groups 
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according to existence of electrical stimulation and the application 
method of rhBMP-2. In Group 1, rhBMP-2 was mixed with 
hydrogel, and electrical stimulation was not applied although the 
electrode was set into the PCL outer box. In Group 2, rhBMP-2 
was added in same manner as in Group 1, but electrical stimulation 
was applied. In Group 3, electrical stimulation was applied, and 
rhBMP-2 was injected to the defect site directly (5μg/defect) 1 
week after the end of the electrical stimulation. 
 
2.2.7.2 Animal experiment process 
 
For anesthesia, Zoletil (20mg/kg) and Rompun (10mg/kg) were 
used. For the fabrication of the bone defect, a resection (1.5 cm 
long and 0.7 cm high from the inferior border of the mandible) of 
the mandibular body was done, where alveolar bone with teeth was 
preserved with continuity with the residual mandibular bone; 
because mandibular stabilization with miniplates after the resection 
of mandibular body including the alveolar bone with teeth would be 
unstable, the loosening of the miniplate and screws was highly 
expected due to the strong jaw movement. The PCL outer boxes 
which contain the electrode, hydrogel, and hBMSCs seeded on the 
collagen sponge were implanted into each defect site and the 
incision sites were then sutured. After the surgery, in Groups 2 and 
3, electrical stimulation was applied for 1 week. In the case of 
Group 3, after 1 week of electrical stimulation, rhBMP-2 
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(5μg/defect) was injected into the defect site using a disposable 
syringe. Four weeks after surgery, the animals were sacrificed and 
quantitative evaluations of new bone formation were conducted 
using soft x-ray analysis, micro-CT analysis and histology with 
H&E staining. Every animal experiment was performed in 
accordance with the “Recommendations for Handling Regulations 
for Laboratory Animals for Biomedical Research” compiled by the 
Committee on the Safety and Ethical Handling Regulation for 






Figure 2.14 The entire process of bone regeneration experiment 
 
2.2.8 Assessment of bone regeneration  
 
2.2.8.1 Soft x-ray  
 
After harvesting the mandibular body, including the defect, a soft 
x-ray was taken with a cabinet-style soft x-ray unit (CMB-2, 
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Softex Co. Japan) The radiographic parameters were 30 kVp and 2 
mA, the exposure time was 90 seconds. 
     
2.2.8.2 micro CT 
 
The mandibular body including the defect and PCL outer box was 
harvested from the skull and fixed in 10% formalin for 1 week. 
Micro CT scans were taken for quantitative evaluations of new bone 
formation using the SkyScan 1172® microfocus x-ray system 
(SkyScan, Kontich, Belgium) with CT software of CTAn 1.8®, 
CTvol, and NRecon reconstruction® (SkyScan). The SkyScan 1172 
microfocus x-ray system is equipped with a microfocus x-ray tube 
with a focal spot of 2 mm, producing a cone beam that is detected 
by a 12-bit cooled x-ray camera CCD fiber-optically coupled to a 
0.5 mm scintillator. The resulting images were 2000 x 1048-pixel 
square images with an aluminum filter used to produce optimized 
images. Reconstructions and analyses were performed using 
NRecon reconstruction and CTAn 1.8 software, respectively. A 
second-order polynomial correction algorithm was used to reduce 
the beam-hardening effect for all samples. To measure newly 
formed bone, a circular area of a pre-defined size was selected as 
the region of interest (ROI) in two-dimensional images. The pixel 
zone representing ossification in the defined ROI was then 
reconstructed in 3D by creating a volume of interest (VOI) in the 
lower and upper ranges of the threshold using grayscale units. After 
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using CTAn 1.8 on each reconstructed BMP file, the bone volume, 
bone density, trabecular thickness, trabecular seperation, and 
trabecular number were obtained using a CT-analyzer in direct 3D 
based on a surface-rendered volume model according to the 
manufacturer’s instructions. To measure the bone mineral density, 
attenuation data for ROI or VOI were converted to Hounsfield units 
and expressed as a value of the bone mineral density using a 
phantom (SkyScan). This phantom contained rods of calcium HA 
(CaHA) having a standard density corresponding to rabbit bone, 
which ranges from 1.26 to 1.65 g/cm3. BMD values were expressed 
in grams per cubic centimeter of CaHA in distilled water. A zero 
value for bone mineral density corresponded to the density of 
distilled water alone (no additional CaHA), and a value greater than 
zero corresponded to non-aerated biologic tissue 
 
2.2.8.3 Histochemical staining 
 
After 3D reconstruction of the micro CT images, the scaffold was 
decalcified in an ethylenediaminetetraacetic acid solution (7%, 
pH=7.0) for 3–4 days. The specimens were then dehydrated in 
70% ethanol and embedded in paraffin. For histochemical staining, 
decalcified paraffin sections were cleaned for 10 min with xylene 
and stained with Masson’s trichrome (MT) for the detection of 
bone structures. Digital images of the stained sections were 
collected using a transmission and polarized light Axioskop 
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microscope (Olympus BX51, Olympus Corporation, Tokyo, Japan). 
The decalcified specimens were cut in the buccolingual direction at 
the middle height of the bone defect area 
 
2.3 LCP based implantable bone regeneration device 
 
2.3.1 Device configuration 
 
LCP based bone regeneration device has a shape of graft 
containment system itself so it is able to contain stem cell graft. 
Also a current generator chip, a pair of electrode for delivery of 
electrical stimulation to cell graft, an inductive link for power 
receive from external power transfer device are embedded in the 
LCP device. Using LCP film, it is possible to make multi-layered 
structure. LCP film has characteristics of high hermeticity and very 
low moisture absorption rate. There characteristics of LCP film 
allow that setting electronics inside the LCP based device. LCP is 
thermal plastic material so it is easy to make various three 
dimensional structure by heat treatment. And a high 
osseointegration property of LCP makes the LCP device as a bone 
substitute itself. Figure 2.15 is a conceptual art of LCP based 





Figure 2.15 A conceptual art of LCP based implantable bone 
regeneration device 
 
The device is designed as a shape which can be applied to rabbit 
mandibular defect model. The device dimension is 15 x 7 x 7 mm. It 
consists of a bottom plate which has an inductive coil and a current 
generator chip and two sidewalls which have a pair of gold 
electrode. Between the sidewalls a proper size of cell graft is 
loaded. Figure 2.16 demonstrates the entire process of producing 







Figure 2.16 The entire process of producing LCP based bone 
regeneration device 
 
On the each layer of LCP film, electrode, inductive coil and PCB is 
designed respectively. And all of the film is unitized by heat press 
process. From the lowest, bottom layer, coil layer, PCB later, 
electrode layer and cover layer are positioned. And between the 
each layer there is adhesion layer made by LCP film that melts at 
lower temperature compare to basic layers. There is dummy layer 
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that protects chip from heat press process. Through heat press 
process the unitized LCP films processed in to shape that can 
contain a cell graft by heat formation process.  
 
2.3.2 LCP layers for bone regeneration device 
 
LCP layer group for bone regeneration device includes electrode 
layer, inductive coil layer, PCB layer, cover layer, bottom layer, 
dummy layer and adhesion layer. LCP films that used in this device 
are two types, CTF and FA. The main difference of two films is 
melting temperature. CTF is melted at 310 degree and FA is melted 
at 285 degree, lower temperature than CTF film. The bottom layer, 
cover layer, coil layer, PCB layer and electrode layer were made by 
CTF film and other layer is made by FA film. All LCP is offered by 
Kuraray, Tokyo, Japan.  
 
2.3.2.1 Electrode layer 
 
Electrode layer is produced on CTF film of 50 μm thickness 
through shadow masking process. To produce the electrode a 
shadow mask is produced in advance. Figure 2.17 is the feature of 
the shadow mask produced in advance. A size of the shadow mask 





Figure 2.17 The feature of the shadow mask 
 
After cleaning LCP film, the film is cut in the shape of 4 inch wafer. 
Then the LCP film is covered by the shadow mask and set into E-
gun evaporator. At 10-5 torr, 100 nm of titanium and 300 nm of gold 
thin film are deposited. After removing the shadow mask, electrode 
layer is completed. Figure 2.18 shows the produced electrode layer.  
 
 
Figure 2.18 The produced electrode layer 
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2.3.2.2 Inductive coil layer 
 
Inductive coil layer was designed by AutoCad 2011 and produced 
by outsourcing (Flexcom, Korea). Figure 2.19 is the feature of the 
designed inductive coil layer.  
 
 
Figure 2.19 The feature of the inductive coil layer 
 
The coil layer is restricted in the bottom plate of LCP device. The 
size of the bottom plate is 5 mm by 12 mm. This means the coil of 
LCP device is small and has a low Q-factor. Therefore to gain 
higher Q-factor, the coil was designed in multi-layered structure. 
The width of coil line and interval of coil line were 100 μm. Each 
layer has 6 turns of coil. The entire thickness of the coil layer is 





Figure 2.20 The feature of the inductive coil layer 
 
2.3.2.3 PCB layer 
 
Inductive coil layer was designed by AutoCad 2011 and produced 
by outsourcing (Flexcom, Korea). The thickness of PCB layer is 50 
μm. The current generator chip was same chip used in both 
bioreactor and bone regeneration device. The chip was bonded on 
PCB layer through wire bonding and external components were 
assembled. Figure 2.21 demonstrates the produced PCB layer and 




Figure 2.21 PCB layer and wire bonded chip on the layer 
 
2.3.2.4 Other layers 
 
Cover layer and bottom layer were produced in 50 μm of CTF film. 
These layers are the outmost layer of the bone regeneration device 
and protect inner layers. Dummy layer is located into between PCB 
layer and electrode layer so the dummy layer protects the chip and 
component on the PCB layer from damage by heat press. Adhesion 
layer was made by 25μm of FA film and was used to attach each 
layers. Figure 2.22 shows each of layers. 
 
 
Figure 2.22 LCP layers. Cover layer, bottom layer, dummy layer and 




2.3.3 Heat press process and heat formation process 
 
Heat press process is conducted to unitize all LCP layers. And 
through heat formation process, the unitized layers deforms to the 
shape which is able to contain a cell graft. For both of process, 
customized aluminum molds were used. Figure 2.23 and 2.24 show 
two molds for heat press process and heat formation process. 
 





Figure 2.24 The mold for heat formation process 
 
After heat press process, the entire thickness of the LCP device is 
about 1 mm. This thickness is too thick to deform by heat formation 
process. It is necessary to make the commissure of the bottom 
plate and the sidewall thinner than 1 mm. So the mold for hear 
press process has a 1 mm height of triangular structure. The heat 
press process procedure is as in the following. First the current 
stimulator chip and passive components were bonded to the PCB 
layer using wire bonding method or silver paste. Then every layer 
etched with O2 plasma using plasma etcher. The etch process time 
was 5 minute and the power of plasma was 100 W. By plasma 
etching, molecular links of LCP film disconnect and this allows 
easier unitization of each films. After plasma etching, each layer 
was cleaned by N2 air gun shower. Every process was conducted in 
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clean room to prevent micro particle. Before setting LCP layers on 
the heat press process mold, 1 mm thickness of ceramic paper and 
200 μm thickness of Teflon paper were set. The ceramic paper 
makes uniform pressure to LCP layers and the Teflon paper 
prevents sticking of FA film which leaks during heat press process. 
After setting of ceramic paper and Teflon paper, LCP layers were 
set. Then the mold was set into customized heat press machine, 
heat press process was executed. The heat press process is 
conducted at 285 degree with pressure of 200 kg for 30 min. After 
heat press process the unitized LCP layers was cooled down then 
cut into the size to be set into the for heat formation mold. The heat 
formation process also used the customized heat press machine. 
The heat formation process was conducted at 100 degree with 
adequate pressure given manually.  
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Chapter 3 Results 
 
3.1 Cell proliferation results using implantable 
bioreactor  
 
The proliferation of hMSCs was assessed after in vivo cell culture 
using the implantable bioreactor with titanium electrodes. In the in 
vitro experiments, after one week of BEC stimulation with the 
parameters of an amplitude of 40μA, a duration of 100μs, and a 
frequency of 100 Hz, the cell growth of the electrically stimulated 
hMSCs was increased by 19% (p<0.05) compared to the 
unstimulated hMSCs. However, this cell proliferation tendency was 
not repeated in the in vivo experiments using the same type of 
bioreactor. The cell growth of electrically stimulated hMSCs after 
one week of BEC stimulation showed a decreasing trend compared 





Figure 3.1 Cell proliferation result of the in vivo cell culture using the 
implantable bioreactor with titanium electrodes  
 
Otherwise, in the experiments using the implantable bioreactor with 
polyimide electrode, the growth of hMSCs was promoted by BEC. 
The proliferation of hMSCs showed an increasing tendency, with 
22% increase compared to the proliferation result of the 
unstimulated hMSCs. Figure 3.2 shows the cell proliferation result 






Figure 3.2 Cell proliferation result of the in vivo cell culture using the 
implantable bioreactor with polyimide electrode 
 
The morphological appearance of the hMSCs cultured in the 
bioreactor with polyimide electrode was observed by SEM. In figure 
3.3, cell adhesion forms of the group with electrical stimulation and 
the group without electrical stimulation. hMSCs were cultured in the 
collagen sponge for 7 days with electrical stimulation. During the 
culture period, the pores in the sponge became filled with hMSCs 
and secreted extracellular matrix to form a matrix layer resulting in 
the virtual disappearance of the pores. In contrast, the extracellular 
matrix layer was very rare and the porous collagen structure was 





Figure 3.3 Scaled-up features of adhered hMSCs on the collagen 
sponges 
 
RT-PCR was performed using human-specific primer. The 
collagen type I gene was expressed higher in the electrically 
stimulated group in same GAPDH condition. Figure 3.4 shows total 
RNA extraction results of cell proliferation experiments. 
 
 
Figure 3.4 Total RNA extraction results of cell proliferation 




3.2 Bone regeneration results using bone regeneration 
device 
 
3.2.1 Radiological and histological examinations 
 
The new bone formation was evaluated from radiological and 
histological examinations four weeks after surgery in three groups.  
Figure 3.5A shows the defect site of the rabbit mandible used in 
this study. Figure 3.5B, C, D is a radiological image of group 1, 2, 3 
in sequence respectively and figure 3.5E, F, G is histological image 
of group 1, 2, 3 in sequence respectively. Figure 3.5B and E is the 
result of group 1, figure 3.5C, F is the result of group 2 and figure 
3.5D, G is the result of group 3. In the radiograms of the three 
groups, Group 3 showed wider and more enhanced radio-opacity, 
which represented more new bone formation, compared with 
Groups 1 and 2. In the histological examination of the MT-stained 
sections, there was no inflammatory reaction. In Group 1, the 
hydrogel remained within the bone defect, and new bone was 
relatively less formed than in Groups 2 and 3. However, in Groups 2 





Figure 3.5 The illustration of rabbit mandible defect and radiological 




3.2.2. Micro CT analysis 
 
The bone structure and new bone formation were evaluated using 
micro CT software, which calculates morphometric parameters from 
a selected volume of interest. The morphometric parameters are 
listed in Table 3.1. Group 2 demonstrated a significant increase in 
new bone formation compared with Group 1. Group 3 showed a 
higher new bone formation tendency compared with Group 2. Group 
2 showed a higher bone volume by 260% (p<0.01) compared with 
Group 1, and Group 3 showed a higher BV by 442% (p<0.01) 
compared with Group 1. The surface of the new bone normalized to 
the real defect volume, trabecular numbers, and the degree of 
connectivity showed a tendency similar to that of bone volume. The 
bone density of Groups 2 and 3 showed higher fold values of 206% 
(p<0.01) and 296% (p<0.01), respectively, compared with Group 1. 
The trabecular numbers of Groups 2 and 3 showed higher fold 
values of 220% (p<0.01) and 372% (p<0.01), respectively, 
compared with Group 1. The trabecular connectivity in Groups 2 
and 3 showed higher fold values of 208% (p<0.05) and 284% 
(p<0.01), respectively, compared with Group 1. The trabecular 
thickness in Groups 2 and 3 showed a higher tendency by ratios of 
121% and 117%, respectively, compared with Group 1. The 
trabecular separation in Group 2 was 95% compared to Group 1, 
while that in Group 3 was 90% compared with Group 1. The total 
bone mineral density of Groups 2 and 3 showed higher values with 
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ratios of 103% (p<0.01) and 107.5% (p<0.01), respectively, 
compared with Group 1. The partial bone mineral density of Groups 
2 and 3 showed higher values with ratios of 104.9% (p<0.01) and 
122.4% (p<0.01), respectively, compared with Group 1. 
 
Table 3.1 Evaluation and summery of the micro CT analysis  
Morphometric 
Parameters 
Fold Value (Ratio to Group 1) 
Group 2 Group 3 
Bone volume  2.6 ** 4.42**, †† 
Bone density 2.06 ** 2.96**, † 
Trabecular thickness  1.21 1.17 
Trabecular number 2.20 ** 3.72 **, †† 
Trabecular separation  0.95 0.90 
Connectivity 2.08 * 2.84** 
Total bone mineral 
density  
1.03** 1.075 **, †† 
Partial bone mineral 
density 
1.049** 1.224**, †† 
(Significant difference from group 1, *p<0.05, **p<0.01 and 




Chapter 4 Discussion 
 
4.1 Implantable bone regeneration device for bone 
graft transplantation therapy 
 
In this study, development of an implantable bone regeneration 
device which is capable to induce electrical stimulation into bone 
defect is demonstrated. The device is applicable to bone graft 
transplantation. Using this device, bone regeneration was evaluated. 
For the development of the bone regeneration device, an 
implantable bioreactor that can culture stem cell grafts using 
electrical stimulation in in vivo bioreactor circumstance was 
developed as first step. The electrodes used in the bioreactor were 
titanium electrode pair and polyimide electrode. The flexible 
polyimide electrode can deliver electrical stimulation effectively to 
local three-dimensional tissue by changing the shape of the 
electrode fitting to the target tissue. Therefore the bone 
regeneration device for rabbit mandible defect model was produced 
by improving the bioreactor device with polyimide electrode. And 
using this device, bone regeneration experiment combined 
treatment of electrical stimulation and injection of growth factor, 
BMP-2 was executed. The produced device in this study had a pair 
of flexible polyimide electrode shaped a plate form and the device 
could deliver electrical stimulation to three-dimensional bone 
defect site or entire of bone graft through effect of electric field 
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unlike conventional bone regeneration device. By using the flexible 
electrode the device in this study can be used in not only rabbit 
mandible defect model but also in various forms of bone defect 
model and the defect has three-dimensional area. Also this device 
can be applied to deliver electrical stimulation locally into bone graft 
for bone regeneration and various biological tissues.  
 
4.2 Selection of the electrical stimulation parameters  
 
Electrical stimulation regulates cell membrane potential in form of 
ionic current. Then regulated membrane potential activates 
voltage-gated calcium channel. From the event, intracellular 
calcium concentration increases, then calcium/calmodulin pathway is 
activated. As the result, electrical stimulation induces secretion of 
cytokine which is necessary for proliferation and differentiation of 
osteoblast cell and accelerates bone mineralization. Furthermore the 
used electrical stimulation is activated cellular process of stem cells 
and helps in cell proliferation and bone regeneration from the 
results of in vivo cell proliferation experiment using the implantable 
bioreactor and the bone regeneration device. However, the 
electrical stimulation parameters for in vivo bone regeneration 
should be set carefully. 
According to parameter of electrical stimulation, it is possible that 
the creation of reactive oxygen species through an oxidation 
reduction process due to the Faradaic reaction near the electrode 
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rather than encouragement of bone repair. Also too high strength of 
the electric field may lead to cell damage by Joule heating effect. 
Improper stimulation parameters can cause bone resorption, rather 
bone regeneration. The electrical stimulation parameters used in 
this study was bi-phasic charge-balanced current stimulation. The 
charge-balanced BEC pulse stimulation has some advantages 
compare with voltage stimulation. The charge delivered to the cell 
in the form of ionic current is important factor for regulation of 
cellular process. In case of the voltage stimulation, the amount of 
delivered charge changes according to the status of electrode even 
though constant voltage is applied. However in case of current 
stimulation, unless varying the impedance between cell and 
electrolyte significantly, it is possible to deliver a constant charge 
regardless of the status of electrode. This means that safe and 
reliable electrical stimulation is possible in the range of generating 
cellular processes. In addition the current stimulation strategy using 
charge-balanced pulse can suppress pH changes due to charge 
accumulation and the creation of reactive oxygen species. So it is 
possible that preventing electrode corrosion and cell damage. 
Furthermore it was reported in previous study of bone regeneration 
using rabbit that the current pulse of 10~20μA is effective in bone 
regeneration [77]. The conventional bone regeneration devices use 
that current pulse parameter [56]. The stimulation parameters used 
in this study were the parameters that augment cell proliferation 
and improve the cell viability of hBMSCs [4]. Also, these 
parameters had the obvious effect of increasing cell proliferation, 
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up-regulating ALP, IGF-1 and TGF-beta1 and causing the early-
stage induction of VEGF, which is necessary for bone formation. 
From these preliminary inspections, the stimulation parameter was 
set and through this parameter the results of cell proliferation and 
bone regeneration were obtained.  
 
4.3 An alternative tissue engineering method of in situ 
stem cell therapy using intracorporeal cell culture 
 
In this study bone regeneration was conducted using combined 
treatment of stem cell graft, hydrogel, collagen sponge and PCL in 
in vivo bioreactor circumstance using electrical stimulation. 
Especially the produced bone regeneration device allows 
simultaneous use of electrical stimulation and growth factor which 
were important morphogenetic signals for improvement of bone 
formation. So this device can be applied with in situ stem cell 
application and intracorporeal cell expansion. The characteristic of 
this regeneration strategy follows. First, in this strategy, the 
regeneration is conducted by cell culture at in vivo bioreactor 
circumstance, so the stem cell can be used at surgery just after 
harvest stem cell without long period of in vitro cell culture about 
more than a month. Through this method, it is possible that 
reduction of cell culture period, cost for cell culture and risk of 
infection. Also enhanced survive of injected stem cell is expected 
by up-regulated cell viability. Second, through this strategy, it is 
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possible that regulation of growth factor and electrical stimulation at 
in vivo. Although cell culture circumstance with cellular process 
regulation is the characteristic of in vitro cell culture method, using 
this device and strategy the advantage of cellular process regulation 
is expected even in in vivo culture. Therefore, the method of 
delivering electrical stimulation at the stage of new bone formation 
can overcome the obstacles of fewer stem cells for large bone 
defects, leading to the expectation of better bone regeneration. This 
study is thus a preliminary study of an alternative tissue 
engineering method that can avoid shortcomings such as a long cell 
culture period, a high cost and an increased risk of infection from 
the extracorporeal in vitro cell culturing processes used in ordinary 
tissue engineering. The method promotes cell expansion and 
induces tissue repair by seeding promptly separated stem cells 
from the blood of bone marrow on a scaffold of a collagen sponge 
followed by implantation into the tissue defect area in conjunction 





Figures 4.1 Concept of the conventional tissue regeneration therapy 
using in vitro cell culture and the intracorporeal cell culture 
 
 
4.4 Transfer of electrical stimulation according to 
electrode design of bioreactor  
 
There is no difference but the shape of electrode between the 
bioreactor with the pair of titanium electrodes and the bioreactor 
with the polyimide electrode. But in the cell proliferation results of 
in vivo cell culture experiment, a contrast tendency was observed. 
The obvious cell proliferation result was gained at in vitro 
experiment using same stimulation parameters. So the result from 
the experiment with titanium electrode was an unexpected result. 
From the result of cell proliferation using titanium electrode did not 
have a high significance, it may be supposed that the transfer of 
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electrical stimulation using titanium electrodes was not sufficient. 
First of all, the titanium electrode uses a tungsten wire for 
connection between the electrode and the power supply device. For 
the electrode and the wire were connected by the pair of volt and 
nut without welding or soldering so there was possibility of a 
connection line break or an insufficient connection. Moreover as 
shown in figure 4.2, in the case of titanium electrode, the electrodes 
are exposed at the outside of the chamber but the inside of chamber, 
the current path which flows along to the outside of the chamber 
may be formed by these exposed electrodes. From this, the 
electrical stimulation which should be concentrated to the cell graft 
inside of the chamber could be distributed to outside of the chamber. 
Also the collagen sponge has a higher electrical impedance compare 
with the muscle. So the current path might be formed along to the 
outside of the chamber and the cell was not affected by electrical 
stimulation sufficiently. Therefore, when delivering electrical 
stimulation to the selected target, the design of the electrode should 
be considered carefully in order to be delivered the most part of the 





Figure 4.2 The current pathway in the bioreactor using titanium 
electrodes  
 
4.5 Bone regeneration effect on combined treatment 
of electrical stimulation and BMP-2  
 
From the bone parameters determined by micro CT, there was a 
significant increase of new bone formation in the group applied 
complex treatment of electrical stimulation and BMP-2 compared 
with the group applied BMP-2 only. The difference between the 
two groups was caused by the existence of the electrical 
stimulation. Therefore, it is clear that the different elevation of the 
bone regeneration between two groups was derived from the 
electrical stimulation. From the differences in the bone parameters 
according to treatment time of BMP-2, finding the most effective 
application time of rhBMP-2 is regarded as important for the 
acceleration of bone formation combined with electrical stimulation. 
A better new bone formation trend was obtained in the case of 
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direct injection of rhBMP-2 to the defect site after electrical 
stimulation compared with a sustained release of rhBMP-2 to the 
defect site during hydrogel degradation. In figure 4.3, the 
conceptual process for the different proliferation and differentiation 
of stem cells. BMP-2 acts by promoting cell differentiation whereas 
cell proliferation effect of BMP-2 is small [81]. Electrical 
stimulation helps stem cell proliferation, cytokine release and 
growth factor induction. While stem cells differentiate to 
osteoblasts directly instead of proliferating via BMP-2 despite the 
use of electrical stimulation. Better new bone formation results in 
Group 3 were noted compared to those of Group 2. The effect of 
cell proliferation by electrical stimulation was decreased due to the 
differentiation of stem cells by the gradually released BMP from the 
hydrogel carrier. In contrast, in Group 3, plenty of stem cells 
proliferated by electrical stimulation were differentiated more into 
osteoblasts compared to the cells in Group 2 when BMP-2 was 
injected after electrical stimulation. Therefore, when using a 
combined treatment of electrical stimulation and rhBMP-2, an 
improvement of new bone formation can be expected when 
electrical stimulation for cell expansion comes first and rhBMP-2 
application follows instead of a sustained release of BMP-2 through 





Figure 4.3 The conceptual process for the different proliferation and 
differentiation of stem cells  
 
4.6 Potential for chronic bone substitute of LCP-
based bone regeneration device LCP 
 
Although the designed bone regeneration device was effective for 
bone healing using bone graft transplantation, there are some parts 
should be improved. First the bioreactor and bone regeneration 
device use a battery for power supply to current stimulator. So 
there are limitations for the setting of parameters, amplitude, 
duration, and frequency and stimulation period of the electrical 
stimulation. And the hermeticity of silicone rubber is lower than the 
hermeticity of metal or ceramic and the silicone package. And the 
electrodes are not packaged as a monolithic material. Therefore if 
the device is implanted for long period, there is a risk of the 
penetration of body fluid into the device and this may occur a failure 
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of the device or infection through toxic product from the corroded 
device. Furthermore the current stimulator and battery were 
packaged together the implant package became large. From the size 
of the package, the bioreactor part and the package part were 
separated and connected by long connection line and it is required 
for additional surgery for implantation of the connection line and 
extraction of the device after healing. From these limitations, the 
requirements for the implantable device for bone regeneration are 
suggested. First, in the setting of stimulation parameter flexibility is 
required. Second, the package of current stimulator should be 
hermetic to prevent a failure of electronics by a body fluid 
penetration or dissolution of the packaging material during 
implanted period. Last, the bioreactor itself should have a high 
osteointegrity because the device is used for bone regeneration and 
the device remains in the body. Therefore the LCP based 
implantable bioreactor device can be used as improved bone 
regeneration device that overcome the limitations mentioned above. 
There are some advantages using the suggested LCP-based bone 
regeneration device. First, utilizing the characteristic of LCP film 
that allows multi-layered structure, it is possible that current 
stimulator and inductive link for power receive can be combined in 
bioreactor. Second, power is delivered by inductive link so 
electrical parameter can be selected with flexibility. Third, LCP is 
implantable for long term without failure of electronics inside of the 
package and infection through electronics because it has very inert 
chemical reactivity and very low moisture absorption. Fourth, the 
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LCP is highly osseo-integratable itself, so LCP bioreactor can be 
used as bone substitute itself. From these characteristics, the LCP-
based bone regeneration device provides a bioreactor circumstance 
embedded an electrical stimulation device and it can act a chronic 
bone substitute. Also after bone regeneration through additional 











Chapter 5 Conclusion 
 
In the present study, the implantable bioreactor and bone 
regeneration device using electrical stimulation that can be applied 
to stem cell grafting were developed. Using the bioreactor device, 
cell proliferation and up-regulation of cell viability were achieved. 
The bone regeneration experiment using the bone regeneration 
device, new bone formation was increased. Also LCP based bone 
regeneration device is introduced as an improved implantable bone 
regeneration device. The device in this study can be used an 
intracorporeal cell culture platform, so it can be alternative of cell 
culture system that overcome limitations of conventional cell 
culture system. The device introduced in this study suggested to 
several limitations of conventional implantable bone regeneration 
device. The bone regeneration device is feasible to be applied in 
three dimensional bone grafting. As an “All in one device”, LCP 
device does not need additional surgery. It acts electrical stimulator, 
bone substitute and graft containment system. For future work, 
stimulation parameter regulation using data telemetry and various 
shape of bone regeneration device can be used to various bone 
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국   
 
 자극  이 닉 커런트  태  포  막 를 변 시킴  
포  포 동  조 시킨다.  자극  포  증식 과 건강도를 
향상시키는 효과가 있 며, 높  골 도  가진 리  자극 써 골 
포  분 , 골  진  칼슘 도 등 골 회복에 도움  주는 효과
를 가지고 있다.  자극  이용  골 재생 장 가 상용 어있지만, 
량  골 결손에 용 는 골 조직편 이식 에 용 는데는 장  
태   자극  달에  어 움이 있다.   
이에 본 논 에 는  자극  3차원 태  골 조직편에 집  
달   있는 체내 이식   자극 장 를 계 고, 동  골 
결손 모델에 용 여 골 결손에  재생 도를 평가 다. 골 재생 
장  개  사  단계 ,  자극  이용 여 체내 포 양    
있는 이 리액  장 를 자인 다. 이를 이용 여 라겐 스펀지
에 종  인간 간엽 포에  자극  인가 며 체내 양
다.  자극  인가 여 포를 양  그룹   자극  인가 지 
않고 양  그룹에 해 포 가 23% 만큼  증가했 며,  
포가 라겐 스펀지에 보다 잘 착 는 등  포 건강도 향상  결
과를 얻었다.  
이 리액  장 를 용 여 골 결손이 생  부 에  포편과 
 자극 극  이식 여 포를 골 조직  도 는 식  골 
재생 법  통해 토끼 악골 결손에  골 재생 실험  행 다. 
동  골 결손 태에 맞도  폴리이미드 극  작 고,  자
극 장 는 실리  다.  자극   그룹이 그 지 않  
그룹에 해 신생골 부 가 260% 만큼 욱 재생 는 결과를 롯 여 
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 자극  인가  그룹이 다양  골 재생 에   우  신생골 
 결과를 얻었다.  
이후 골 이 뛰어나고 이 우  액  크리스탈 폴리
(LCP)를 장  질  사용 고,   송 장   자
극 생  장 를 내장  LCP  골 재생 장 를 작 다. 이 장
는 골 조직편  지지해주는 골 지지체  역 과  자극 장  역
 동시에 행   있다.  
이상  결과들  골 결손에 직   자극  인가   있는 체내 이식
 골 재생 장 를 이용  골 재생 시 이, 골 결손  회복   효과
이고 새 운 법이   있  보여주며, 나아가 LCP를 이용  이
식  골 재생 장  개   체내 포 양과  자극이 결합  조
직편 이식 시  개   용    있다.  
 
주요어 :  자극. 이식  장 . 골 재생. 포. LCP 
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